Ayala Pharmaceuticals is based in Rehovot, Israel. It has raised $47M in total funding. Latest round: Series B.
Ayala Pharmaceuticals is based in Rehovot, Israel. Ayala Pharmaceuticals has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2019. The round record for Ayala Pharmaceuticals runs through 2019; nothing later has been disclosed. Investors on record include Novartis, SBI JI Innovation Fund, Israel Biotech Fund, aMoon, Harel Insurance & Finance Group. 5 distinct backers are named across the disclosed rounds.
Every Ayala Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Rehovot at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026